Literature DB >> 19731086

Oncogenes do not Fully Override Cell-intrinsic Traits: Pronounced Impact of the Cellular Programme.

Józefa Węsierska-Gądek1, Eva Walzi1, Iva Dolečkova1, Gerald Schmid2.   

Abstract

Overexpression of p53 tumor suppressor protein in malignant cells induces cell cycle arrest, or alternatively, apoptosis thereby indicating that additional factors may contribute to the p53-mediated outcome. Comparison of the experimental protocols revealed that the construct encoding wild-type (wt) p53 was expressed in cells of different origin. Therefore, we decided to determine whether the intrinsic cellular program of primary cells of the same genetic background could have any effect on the oncogenic potential of mutated c-Ha-RAS and TP53. Primary rat cells (RECs) isolated from rat embryos of different age: at 13.5 gd (y) and 15.5 gd (o), were used for transfection. Immortalized rat cell clones overexpressing temperature-sensitive (ts) p53(135val) mutant and transformed cell clones after co-transfection with oncogenic c-Ha-Ras, were generated. The ts p53(135Val) mutant, switching between wt and mutant conformation, offers the possibility to study the role of p53 in cell cycle control in a model of malignant transformation in cells with the same genetic background. Surprisingly, the kinetics of cell proliferation at non-permissive temperature and that of cell cycle arrest at 32°C strongly differed between cell clones established from yRECs and oRECs. Furthermore, the kinetics of the re-enter of G1-arrested cells in the active cell cycle strongly differed between distinct cell clones. Finally, the susceptibility of immortalized and transformed cells to the pharmacological inhibitors of cyclin-dependent kinases (CDKs) considerably differed. Our results clearly show that overexpression of genes such as mutated TP53 and oncogenic c-Ha-RAS is not able to fully override the intrinsic cellular programme.

Entities:  

Keywords:  Cell cycle arrest; Cell synchronization; FPTase; FTI; Signal transduction; c-Ha-Ras; p53 tumor suppressor

Year:  2009        PMID: 19731086      PMCID: PMC2756341          DOI: 10.1007/s12307-009-0024-9

Source DB:  PubMed          Journal:  Cancer Microenviron        ISSN: 1875-2284


  48 in total

1.  Direct involvement of p53 in the base excision repair pathway of the DNA repair machinery.

Authors:  H Offer; R Wolkowicz; D Matas; S Blumenstein; Z Livneh; V Rotter
Journal:  FEBS Lett       Date:  1999-05-07       Impact factor: 4.124

2.  Transgenic mouse model for studying the transcriptional activity of the p53 protein: age- and tissue-dependent changes in radiation-induced activation during embryogenesis.

Authors:  E Gottlieb; R Haffner; A King; G Asher; P Gruss; P Lonai; M Oren
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

Review 3.  The Li-Fraumeni syndrome: an inherited susceptibility to cancer.

Authors:  S C Evans; G Lozano
Journal:  Mol Med Today       Date:  1997-09

4.  p53 Transgenic mice are highly susceptible to 4-nitroquinoline-1-oxide-induced oral cancer.

Authors:  Zhongqiu Zhang; Yian Wang; Ruisheng Yao; Jie Li; Ronald A Lubet; Ming You
Journal:  Mol Cancer Res       Date:  2006-06       Impact factor: 5.852

5.  A new multiplex assay allowing simultaneous detection of the inhibition of cell proliferation and induction of cell death.

Authors:  Józefa Wesierska-Gadek; Marieta Gueorguieva; Carmen Ranftler; Gerlinde Zerza-Schnitzhofer
Journal:  J Cell Biochem       Date:  2005-09-01       Impact factor: 4.429

6.  Phosphorylation regulates the interaction and complex formation between wt p53 protein and PARP-1.

Authors:  Józefa Wesierska-Gadek; Jacek Wojciechowski; Gerald Schmid
Journal:  J Cell Biochem       Date:  2003-08-15       Impact factor: 4.429

Review 7.  DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis.

Authors:  Carol Bernstein; Harris Bernstein; Claire M Payne; Harinder Garewal
Journal:  Mutat Res       Date:  2002-06       Impact factor: 2.433

Review 8.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

Authors:  M S Greenblatt; W P Bennett; M Hollstein; C C Harris
Journal:  Cancer Res       Date:  1994-09-15       Impact factor: 12.701

9.  Differential transactivation by the p53 transcription factor is highly dependent on p53 level and promoter target sequence.

Authors:  Alberto Inga; Francesca Storici; Thomas A Darden; Michael A Resnick
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

Review 10.  p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology, and cancer risk assessment.

Authors:  C C Harris
Journal:  Environ Health Perspect       Date:  1996-05       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.